Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
VECT-HORUS
About
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €3.50M
- Industries
- Biopharma,Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain, organs, and tumors. The vectors target receptors involved in “Receptor-Mediated Transport” (RMT, a physiological system for the transport into cells of endogenous substances by combining drugs or imaging agents to its vectors, VECT-HORUS allows them to cross biological barriers that restrict access to their target, notably the blood-brain barrier (BBB).Founded in 2005 by Alexandre Tokay and Dr. Michel Khrestchatisky, the biotech company is based in Marseille, Marseille, Provence-Alpes-Cote d'Azur.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 7, 2018 | Series Unknown | €3.50M | 3 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
